| Retracted article: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 JY Krzeszinski, W Wei, HD Huynh, Z Jin, X Wang, TC Chang, XJ Xie, L He, ... Nature 512 (7515), 431-435, 2014 | 371 | 2014 |
| Toward An Understanding of The Protein Interaction Network of The Human Liver Mol Syst Biol 7 (536), 2011 | 288 | 2011 |
| A liver-bone endocrine relay by IGFBP1 promotes osteoclastogenesis and mediates FGF21-induced bone resorption X Wang, W Wei, JY Krzeszinski, Y Wang, Y Wan Cell metabolism 22 (5), 811-824, 2015 | 153 | 2015 |
| New therapeutic targets for cancer bone metastasis JY Krzeszinski, Y Wan Trends in pharmacological sciences 36 (6), 360-373, 2015 | 106 | 2015 |
| Orexin regulates bone remodeling via a dominant positive central action and a subordinate negative peripheral action W Wei, T Motoike, JY Krzeszinski, Z Jin, XJ Xie, PC Dechow, ... Cell metabolism 19 (6), 927-940, 2014 | 45 | 2014 |
| XPC promotes MDM2-mediated degradation of the p53 tumor suppressor JY Krzeszinski, V Choe, J Shao, X Bao, H Cheng, S Luo, K Huo, H Rao Molecular biology of the cell 25 (2), 213-221, 2014 | 34 | 2014 |
| Ubiquitin Ligase Ufd2 Is Required for Efficient Degradation of Mps1 Kinase Liu C, van Dyk D, Choe V, Yan J, Majumder S, Costanzo M, Bao X, Boone C, Huo ... J Biol Chem 286 (51), 43660-7, 2011 | 30 | 2011 |
| Rad4 Regulates Protein Turnover at a Postubiquitylation Step HR Yue Li, Jing Yan, Ikjin Kim, Chang Liu, Keke Huo Mol Biol Cell 21 (1), 177-185, 2010 | 24 | 2010 |
| Lipid osteoclastokines regulate breast cancer bone metastasis JY Krzeszinski, AG Schwaid, WY Cheng, Z Jin, ZR Gallegos, ... Endocrinology 158 (3), 477-489, 2017 | 22 | 2017 |
| A newly identified Pirh2 substrate SCYL1-BP1 can bind to MDM2 and accelerate MDM2 self-ubiquitination KH Jing Yan, Di Zhang, Yujun Di, Huili Shi, Hai Rao FEBS letters 584 (15), 3275-3278, 2010 | 22 | 2010 |
| Overexpression of SCYL1-BP1 stabilizes functional p53 by suppressing MDM2-mediated ubiquitination HRKH Jing Yan, Yujun Di, Huili Shi FEBS Letter 584 (20), 4319–4324, 2010 | 21 | 2010 |
| Abstract P6-17-01: MicroRNA-34a suppresses breast cancer bone metastasis by inhibiting osteoclastogenesis and targeting tgif2 JY Krzeszinski, W Wei, HD Huynh, Z Jin, X Wang, TC Chang, X Xie, L He, ... Cancer Research 75 (9_Supplement), P6-17-01-P6-17-01, 2015 | 3 | 2015 |
| Author Correction: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (Nature,(2014), 512, 7515,(431-435), 10.1038/nature13375) JY Krzeszinski, W Wei, HD Huynh, Z Jin, X Wang, TC Chang, XJ Xie, L He, ... Nature, 2019 | 2 | 2019 |
| miR-34a blocks osteoporosis and cancer bone metastasis by inhibiting* osteoclastogenesis and Tgif2 JY Krzeszinski, W Wei, HD Huynh, Z Jin, X Wang, TC Chang, XJ Xie, L He, ... CLINICAL & EXPERIMENTAL METASTASIS 32 (3), 245-245, 2015 | 1 | 2015 |
| Nmes1 antibodies and methods of use thereof N Zhang, Z An, KU Zhiqiang, WAN Yihong, J Krzeszinski US Patent App. 17/332,790, 2021 | | 2021 |
| Bimolecular Fluorescence Complementation Assay: Application in The Study of Protein-protein Interaction HKK Yan Jing Progress in Biochemistry and Biophysics 33, 589-595, 2006 | | 2006 |
| 海 外 文 献 紹 介 CJIS CAN 情報管理 23 (1), 1980 | | 1980 |
| v Remaining hurdles to effective cancer therapy MS Ewer, SM Ewer, L Rochette, C Guenancia, A Gudjoncik, O Hachet, ... | | |